Published in Clin Infect Dis on February 15, 2006
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med (2010) 5.36
Double-blind clinical trial to compare autologous fat grafts versus autologous fat grafts with PDGF: no effect of PDGF. Plast Reconstr Surg (2014) 3.21
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS (2004) 2.39
[Antiretroviral therapy of HIV infection: duration and reasons for changing the first therapeutic regimen in 518 patients]. Med Clin (Barc) (2006) 2.14
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr (2004) 2.11
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section. AIDS (2006) 2.06
[Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy]. Enferm Infecc Microbiol Clin (2011) 2.03
[Main training in medical specialties: a challenge of the present for a better health system]. Med Clin (Barc) (2006) 2.02
[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012]. Enferm Infecc Microbiol Clin (2012) 2.02
[Failure of a special winter programme aimed to alleviate negative effects of winter overload on an emergency department]. Med Clin (Barc) (2008) 1.95
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin Infect Dis (2004) 1.80
[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project]. Med Clin (Barc) (2005) 1.78
Forwarding techniques for IP fragmented packets in a real 6LoWPAN network. Sensors (Basel) (2011) 1.73
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain). J Acquir Immune Defic Syndr (2008) 1.68
Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols. Ann Emerg Med (2003) 1.66
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS (2006) 1.65
A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci Transl Med (2013) 1.62
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003). Enferm Infecc Microbiol Clin (2006) 1.59
Mitochondrial toxicity associated with linezolid. N Engl J Med (2005) 1.52
Statistical reviewers improve reporting in biomedical articles: a randomized trial. PLoS One (2007) 1.49
The effects of sepsis on mitochondria. J Infect Dis (2011) 1.45
Sex differences in the treatment of patients with atrial fibrillation: population-based study in a local health district. Rev Esp Cardiol (2011) 1.45
[Postgraduate medical training in Spain (MIR): a proposal for the adaptation to the sanitary model requirements]. Med Clin (Barc) (2008) 1.43
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infecc Microbiol Clin (2004) 1.42
Considerations about the value of sonography for the measurement of regional body fat. AIDS (2006) 1.41
Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis (2004) 1.41
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study. Antivir Ther (2011) 1.41
[Prognostic value of troponin in patients with acute heart failure attended in Spanish Emergency Departments: TROPICA study (TROPonin in acute heart failure)]. Med Clin (Barc) (2012) 1.40
[Emergency department activity during the 2003 summer heat wave]. Med Clin (Barc) (2005) 1.39
Core competencies in internal medicine. Eur J Intern Med (2012) 1.39
Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis (2002) 1.39
[Adverse effects of antiarrhythmic drugs in patients with atrial fibrillation in primary care]. Med Clin (Barc) (2011) 1.39
[Influence of patient's sex in the form of presentation and the management of acute heart failure in Spanish emergency rooms]. Med Clin (Barc) (2010) 1.39
[Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors]. Med Clin (Barc) (2005) 1.38
[Use of activated charcoal in acute poisonings: clinical safety and factors associated with adverse reactions in 575 cases]. Med Clin (Barc) (2010) 1.38
Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother (2006) 1.38
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients. Antivir Ther (2007) 1.33
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy. Antivir Ther (2003) 1.29
Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol (2003) 1.24
A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study. PLoS One (2011) 1.15
A therapeutic dendritic cell-based vaccine for HIV-1 infection. J Infect Dis (2011) 1.15
Therapeutic vaccines against HIV infection. Hum Vaccin Immunother (2012) 1.11
[Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013]. Enferm Infecc Microbiol Clin (2013) 1.11
Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy. AIDS (2008) 1.11
[Effect of statistical review on manuscript quality in Medicina Clínica (Barcelona): a randomized study]. Med Clin (Barc) (2003) 1.10
Care mechanisms to avoid readmission of patients with chronic obstructive pulmonar disease. Arch Bronconeumol (2013) 1.09
[Situations where natriuretic peptides may be useful]. Aten Primaria (2012) 1.07
Decision algorithms are needed in acute heart failure in the emergency department. J Card Fail (2013) 1.06
Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy. AIDS Rev (2012) 1.05
Effects of external and internal factors on emergency department overcrowding. Ann Emerg Med (2002) 1.04
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum (2002) 1.03
Nevirapine in the treatment of HIV. Expert Rev Anti Infect Ther (2004) 1.01
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. J Acquir Immune Defic Syndr (2009) 0.99
Electron transport chain defects in heart failure. Heart Fail Rev (2002) 0.99
Lipodystrophy and quality of life of HIV-infected persons. AIDS Rev (2008) 0.97
Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy. AIDS (2011) 0.97
Creatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study. J Antimicrob Chemother (2012) 0.97
Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³. AIDS Res Hum Retroviruses (2013) 0.96
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial. Clin Infect Dis (2006) 0.96
Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1. J Virol (2012) 0.95
B-function expression in the flower center underlies the homeotic phenotype of Lacandonia schismatica (Triuridaceae). Plant Cell (2010) 0.95
Mitochondrial damage in adipose tissue of untreated HIV-infected patients. AIDS (2011) 0.94
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients. Antivir Ther (2005) 0.93
Impact of lipodystrophy on the quality of life of HIV-1-infected patients. J Acquir Immune Defic Syndr (2002) 0.93
Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn. AIDS (2012) 0.93
Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. J Acquir Immune Defic Syndr (2004) 0.92
Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients. J Clin Psychopharmacol (2007) 0.92
Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings. Antivir Ther (2005) 0.92